Studies on the Mechanism of the Enhancement of the Antihypertensive Activity of Captopril by A Diuretic in Spontaneously Hypertensive Rats
- 1 January 1982
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension. Part A: Theory and Practice
- Vol. 4 (6) , 1001-1018
- https://doi.org/10.3109/10641968209060768
Abstract
Captopril (30 mg/kg/day orally for two days) in spontaneously hypertensive rats (SHR) inhibited serum angiotensin converting enzyme (ACE) activity 92.3%; increased plasma renin activity (PRA) 18-fold and reduced mean arterial blood pressure (MABP) 19 mm Hg. Hydrochlorothiazide (HCTZ) (100 mg/kg-day 1; 10 mg/kg-day 2, orally) increased PRA 3-fold but did not affect serum ACE or MABP. HCTZ plus captopril inhibited serum ACE 95.2%; increased PRA 38-fold and reduced MABP 47.5 mm Hg. Captopril or HCTZ plus captopril did not alter the responses of isolated aortic strips to norepinephrine (NE), serotonin, angiotensin II (AII) or isoproterenol. Pressor responses of conscious SHR to AII and NE were unaltered by captopril or HCTZ plus captopril although the bradykinin-induced depressor responses were significantly but equally potentiated. These results suggest that the potentiating effect of HCTZ is due to some mechanism that shifts the animal's blood pressure maintenance system to a renin-dependent state and is not due to changes in vascular reactivity.This publication has 15 references indexed in Scilit:
- Effect of the time interval between blood sampling and assay on serum angiotensin I-converting enzyme activity from captopril-treated ratsEuropean Journal of Pharmacology, 1980
- The Effects of Captopril, Propranolol, and Indomethacin on Blood Pressure and Plasma Renin Activity in Spontaneously Hypertensive and Normotensive RatsExperimental Biology and Medicine, 1979
- LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSIONThe Lancet, 1979
- EFFECTS OF CHRONIC TREATMENT WITH CAPTOPRIL(SQ 14,225), AN ORALLY ACTIVE INHIBITOR OFANGIOTENSIN I-CONVERTING ENZYME, INSPONTANEOUSLY HYPERTENSIVE RATSThe Japanese Journal of Pharmacology, 1979
- Long-Term Efficacy of Captopril (SQ 14,225) In 2-Kidney Renal Hypertensive RatsClinical and Experimental Hypertension, 1978
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977
- Lack of Increased Renin-Angiotensin Activity in Rats with Spontaneous HypertensionExperimental Biology and Medicine, 1970
- Application of a Radioimmunoassay for Angiotensin I to the Physiologic Measurements of Plasma Renin Activity in Normal Human Subjects1Journal of Clinical Endocrinology & Metabolism, 1969
- An enzyme in microsomal fraction of kidney that inactivates bradykininLife Sciences, 1967